Carpal Tunnel Surgery Denied by Insurance? How to Appeal Successfully

Carpal tunnel syndrome (CTS) is the most common peripheral nerve compression disorder in the United States, affecting millions of workers and patients. Carpal tunnel release surgery has one of the highest success rates of any outpatient procedure. Yet insurance companies routinely deny this surgery, citing inadequate nerve studies, insufficient conservative treatment, or ambiguous criteria about symptom severity. If your claim was denied, here's what you need to know.

Why Carpal Tunnel Release Claims Get Denied

EMG and nerve conduction study (NCS) not performed or inconclusive. Most insurers require electrodiagnostic testing — specifically electromyography (EMG) and nerve conduction studies (NCS) — before approving carpal tunnel release. These tests measure electrical conduction velocity across the carpal tunnel and can objectively confirm median nerve compression. If studies weren't performed, or if results fell into a borderline range, the insurer may deny the claim.

Conservative treatment not documented as failed. Insurers typically require a trial of conservative measures before approving surgery: wrist splinting (especially at night), corticosteroid injections, activity modification, and ergonomic changes. If your medical records don't clearly show that these treatments were tried and failed to provide lasting relief, the insurer can deny the claim as "conservative treatment not exhausted."

Insufficient duration of conservative treatment. Even when conservative treatment is documented, the insurer may argue the duration wasn't long enough — typically expecting six weeks to three months of consistent splinting, and at least one or two corticosteroid injections.

Clinical diagnosis without electrodiagnostic confirmation. Some surgeons perform carpal tunnel release based on clinical criteria alone (Phalen's test, Tinel's sign, clinical history). Many insurers require electrodiagnostic confirmation, and will deny surgery if only clinical diagnosis is documented.

Severity classification disputes. Nerve conduction studies are typically graded as mild, moderate, or severe. Some insurers apply criteria that only cover surgery for moderate to severe cases, and may deny claims for mild CTS even with significant functional impairment.

Wrong CPT code or bundling issues. Carpal tunnel release can be performed endoscopically or via open technique. Billing errors or incorrect procedure codes can result in automatic denials that look like coverage disputes but are actually administrative errors.

What the Evidence Says

The American Academy of Neurology and the American Academy of Orthopaedic Surgeons both recognize carpal tunnel release as effective and appropriate when conservative treatment has failed. Electrodiagnostic studies are the gold standard for confirming diagnosis, and their results correlate well with surgical outcomes. However, clinical criteria alone can also be sufficient for diagnosis — and some published guidelines note that electrodiagnostic studies are not always required when clinical presentation is unambiguous.

Building Your Appeal

Obtain your EMG and NCS results with interpretation. If studies were performed, request the full report including raw conduction values, not just a summary. The report should document distal latency, amplitude, and conduction velocity in the median nerve across the wrist. Moderately to severely reduced conduction is strong objective support.

Document your conservative treatment timeline. Pull together records of every splint prescription, every injection, every occupational therapy or hand therapy visit. If you purchased an over-the-counter splint, document that too. Your appeal should show a clear timeline of what was tried, for how long, and what the outcome was.

Get a letter from your treating physician or hand surgeon. The letter should address: duration of symptoms, severity (including nighttime waking, hand weakness, dropping objects), electrodiagnostic findings, failed conservative treatment, and why surgical release is the appropriate next step.

Challenge mild CTS denial criteria. If you have mild electrodiagnostic findings but severe functional impairment — including thenar muscle atrophy, inability to perform fine motor tasks, or occupational impact — make this case explicitly. Symptom severity, not just electrophysiologic grade, is a relevant clinical factor.

Request a second opinion if needed. If your surgeon is willing to write a detailed letter but the insurer remains resistant, a second opinion from another board-certified hand surgeon supporting the surgical recommendation strengthens your appeal.

After an Internal Denial

Request an external independent review. Carpal tunnel surgery denials based on conservative treatment not being exhausted are among the most reversible on external review, particularly when you can document a trial of splinting and injection with inadequate relief.

Fight Back With ClaimBack

Carpal tunnel release is one of the most well-supported outpatient surgeries in medicine. A denial doesn't have to stand. ClaimBack helps you build the exact appeal that targets the specific reason your insurer cited.

Start your appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied